Using the AlphaLISA kit, we were able to detect VEGF in small sample volumes (5 μl plasma or serum/well) in premature infants with treatment requiring ROP and to monitor platelet activation by PF-4 detection. This evidence concerns the gene VEGFA and retinopathy of prematurity.